期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 291, 期 47, 页码 24618-24627出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M116.751917
关键词
-
资金
- National Center of Neurology and Psychiatry (NCNP) Intramural Research Grant [26-8]
- Japan Agency for Medical Research and Development (AMED) [16gm0810010h0201, 16gm0810010h0001, 15dk0310041h0002]
- Japan Society for the Promotion of Science [26253057, 16K08262, 23390081, 15H04352, 24687017, 26670499, 16H05353, 24619014]
- Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [26110712, 26110727]
- Mizutani Foundation for Glycoscience [150171]
- Grants-in-Aid for Scientific Research [25460054, 26110712, 24619014, 26253057, 26670499, 15H04352, 23390081, 16K08262, 26110727, 24687017, 16H05353, 16H04758] Funding Source: KAKEN
A defect in O-mannosyl glycan is the cause of alpha-dystroglycanopathy, a group of congenital muscular dystrophies caused by aberrant a-dystroglycan (alpha-DG) glycosylation. Recently, the entire structure of O-mannosyl glycan, [3GlcA beta 1-3Xyl alpha 1](n)-3GlcA beta 1-4Xyl-Rbo5P-1Rbo5P-3GalNAc beta 1-3GlcNAc beta 1-4 (phospho-6)Man alpha 1-, which is required for the binding of alpha-DG to extracellular matrix ligands, has been proposed. However, the linkage of the first Xyl residue to ribitol 5-phosphate (Rbo5P) is not clear. TMEM5 is a gene product responsible for alpha-dystroglycanopathy and was reported as a potential enzyme involved in this linkage formation, although the experimental evidence is still incomplete. Here, we report that TMEM5 is a xylosyltransferase that forms the Xyl beta 1-4Rbo5P linkage on O-mannosyl glycan. The anomeric configuration and linkage position of the product (beta 1,4 linkage) was determined by NMR analysis. The introduction of two missense mutations in TMEM5 found in alpha-dystroglycanopathy patients impaired xylosyltransferase activity. Furthermore, the disruption of the TMEM5 gene by CRISPR/Cas9 abrogated the elongation of the (-3GlcA beta 1-3Xyl alpha 1-) unit on O-mannosyl glycan. Based on these results, we concluded that TMEM5 acts as a UDP-e-xylose:ribitol-5-phosphate beta 1,4-xylosyltransferase in the biosynthetic pathway of O-mannosyl glycan.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据